Simplex Trading’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-5,932
| Closed | -$63.6K | – | 8894 |
|
|
2025
Q3 | $52K | Buy |
+5,932
| New | +$46.1K | ﹤0.01% | 6411 |
|
|
2025
Q2 | – | Sell |
-15,540
| Closed | -$88.9K | – | 8886 |
|
|
2025
Q1 | $75K | Buy |
+15,540
| New | +$129K | ﹤0.01% | 5374 |
|
|
2024
Q2 | – | Sell |
-6,556
| Closed | -$28.2K | – | 8999 |
|
|
2024
Q1 | $16K | Sell |
6,556
-101,520
| -94% | -$229K | ﹤0.01% | 7255 |
|
|
2023
Q4 | $259K | Buy |
108,076
+17,667
| +20% | +$41.5K | ﹤0.01% | 4394 |
|
|
2023
Q3 | $307K | Buy |
90,409
+32,894
| +57% | +$182K | ﹤0.01% | 3921 |
|
|
2023
Q2 | $422K | Buy |
57,515
+30,047
| +109% | +$279K | ﹤0.01% | 3483 |
|
|
2023
Q1 | $284K | Buy |
27,468
+27,301
| +16,348% | +$330K | ﹤0.01% | 3905 |
|
|
2022
Q4 | $1K | Sell |
167
-10,548
| -98% | -$163K | ﹤0.01% | 8807 |
|
|
2022
Q3 | $224K | Buy |
10,715
+7,522
| +236% | +$209K | ﹤0.01% | 4463 |
|
|
2022
Q2 | $99K | Buy |
+3,193
| New | +$109K | ﹤0.01% | 5566 |
|
|
2021
Q4 | – | Sell |
-6,368
| Closed | -$288K | – | 10673 |
|
|
2021
Q3 | $407K | Buy |
6,368
+1
| +0% | +$61 | ﹤0.01% | 4414 |
|
|
2021
Q2 | $401K | Buy |
6,367
+4,761
| +296% | +$306K | ﹤0.01% | 4505 |
|
|
2021
Q1 | $149K | Buy |
+1,606
| New | +$164K | ﹤0.01% | 5189 |
|
|
2020
Q4 | – | Sell |
-6,723
| Closed | -$617K | – | 8492 |
|
|
2020
Q3 | $694K | Buy |
6,723
+1,494
| +29% | +$161K | ﹤0.01% | 2642 |
|
|
2020
Q2 | $413K | Buy |
5,229
+2,479
| +90% | +$185K | ﹤0.01% | 3147 |
|
|
2020
Q1 | $159K | Buy |
+2,750
| New | +$158K | ﹤0.01% | 3854 |
|
|
2019
Q3 | – | Sell |
-633
| Closed | -$29.5K | – | 7371 |
|
|
2019
Q2 | $30K | Sell |
633
-3,052
| -83% | -$146K | ﹤0.01% | 5267 |
|
|
2019
Q1 | $186K | Buy |
+3,685
| New | +$217K | ﹤0.01% | 3700 |
|
|
2018
Q3 | – | Sell |
-1,206
| Closed | -$70.4K | – | 7533 |
|
|
2018
Q2 | $60K | Buy |
+1,206
| New | +$62.8K | ﹤0.01% | 4845 |
|
|
2018
Q1 | – | Sell |
-622
| Closed | -$31K | – | 6294 |
|
|
2017
Q4 | $28K | Buy |
+622
| New | +$26.2K | ﹤0.01% | 2984 |
|
|
2017
Q1 | – | Sell |
-17
| Closed | -$517 | – | 6274 |
|
|
2016
Q4 | $0 | Sell |
17
-1,151
| -99% | -$34.5K | ﹤0.01% | 5971 |
|
|
2016
Q3 | $36K | Sell |
1,168
-3,165
| -73% | -$92K | ﹤0.01% | 2387 |
|
|
2016
Q2 | $121K | Buy |
+4,333
| New | +$170K | 0.01% | 1341 |
|
|
2016
Q1 | – | Sell |
-109
| Closed | -$3.85K | – | 5719 |
|
|
2015
Q4 | $4K | Sell |
109
-678
| -86% | -$23.6K | ﹤0.01% | 4015 |
|
|
2015
Q3 | $22K | Buy |
787
+579
| +278% | +$19.1K | ﹤0.01% | 2683 |
|
|
2015
Q2 | $6K | Buy |
+208
| New | +$6.45K | ﹤0.01% | 3499 |
|
Other funds holding EBS
OHA
Simplex Trading's EBS Position: Q4 2025 in Review
Simplex Trading sold out of Emergent Biosolutions (EBS) in Q4 2025, closing a stake of 5,932 shares — an estimated $63.6K sold.
Simplex Trading first reported a position in EBS in Q2 2015 and held it in 26 quarters. The position peaked at $694K in Q3 2020. 183 funds tracked by Wall St. Rank hold EBS as of Q4 2025.
- Simplex Trading reported no remaining Emergent Biosolutions position as of Q4 2025 after selling out during the quarter.
- Simplex Trading sold 5,932 Emergent Biosolutions shares in Q4 2025, an estimated $63.6K.
- Simplex Trading first reported a position in Emergent Biosolutions in Q2 2015 and held it in 26 quarters.
- Simplex Trading's Emergent Biosolutions position peaked at $694K in Q3 2020.
- 183 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2025.
Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.